quique43 escribió:Clinton Financial
Market Movers
ADR - 66.75
Daily Ticker
Insider News
About Us »
Banco Macro SA (ADR) (NYSE:BMA) Analyst Recommendation Outlook
by Clinton Staff Writer — April 13, 2016
Research firms that cover publicly traded companies have a dedicated workforce of analysts diligently tracking the most popular stocks. Sell-side reports are provided to institutional investors in order to help them make sound investment decisions. The information contained in these reports may also be obtained and used by retail investors as well. Covering analysts usually give Buy, Sell and Hold recommendations along with guidance and company earnings estimates. There are 2 analysts providing ratings for Banco Macro SA (ADR) (NYSE:BMA). 1 have given the stock a “Strong Buy”, 1 rate it a “Buy”, 1 are rating the stock a Hold, and 0 are recommending “Sell”. Every recommendation can be mapped to an integer based scale from 1 to 5. Taking the average of the numerical ratings, the stock has a current consensus recommendation of 2. Following the scale, a 1 rating is equivalent to a Strong Buy and a 5 would be considered a Strong Sell rating.
Investors should undoubtedly be looking ahead to the next company earnings release which is planned to go out on or around 2016-05-09. The consensus on the Street is anticipating that the firm will post earnings of $2.06 per share for the quarter. Analysts may make changes to their models multiple times during the quarter leading up to earnings. The direction of the sentiment is an important factor in where the Street sees the stock going in the future. Compared to the same quarter in the previous year, the company reported EPS of $2.16. Most recently, the firm posted quarterly EPS of $3.37 against the Zacks Research consensus estimate of $2.25. This provided a surprise factor of 49.78% or a numerical difference of $1.12.
Covering Wall Street analysts also issue 12-month target prices on the stocks they track. The 2 analysts providing targets on shares of Banco Macro SA (ADR) (NYSE:BMA) have given a consensus target of $84 on shares. The standard deviation of all the estimates currently stands at $2.828 with the lowest target being $82 and the top estimate predicting the stock to hit $86.
This article is for informational purposes only. The author does not have any position in the stock mentioned and in no way is recommending to Buy or Sell.
Esperemos que se cumpla, hoy hubo mucho más vendedores que compradores pero se la aguantó bastante bien.
Enviado desde mi CHC-U03 mediante Tapatalk